Share
- Release Date: 07/12/12 17:08
- Summary: NTA: MLN: MLN ex-div NAV $0.8068 as at 5/12/12
- Price Sensitive: No
- Download Document 1.57KB
MLN
07/12/2012 15:08
NTA
REL: 1508 HRS Marlin Global Limited
NTA: MLN: MLN ex-div NAV $0.8068 as at 5/12/12
MLN NAV $0.8068 as at 5/12/12 (after deducting 1.67cps dividend payable)
Date 5/12/2012 4/12/2012
MLN NAV $0.8068 $0.8207
Share price close $0.64 $0.68
Discount 21% 17%
The above NAV is unaudited.
The NAV per share is after deducting an accrual for a 1.67 cents per share
dividend to be paid on 21 December 2012 and is also after deducting treasury
stock (shares acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 5 December 2012 are approximately as
follows:
Biotest (Germany) 6%
Stratec Biomedical (Germany) 5%
Sarin Technologies (Israel) 4%
Wasion (China) 4%
Wirecard (Germany) 4%
BACKGROUND
Marlin Global Limited is a listed investment company that invests in
companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00230868 For:MLN Type:NTA Time:2012-12-07 15:08:20
